Pdt Partners, LLC Adaptive Biotechnologies Corp Transaction History

Pdt Partners, LLC

$1.45 Billion
Q3 2025

A detailed history of Pdt Partners, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Pdt Partners, LLC holds 121,517 shares of ADPT stock, worth $1.71 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

121,517

Previous 272,303 55.37%

Holding current value

$1.71 Million

Previous $3.17 Million 42.72%

% of portfolio

0.13%

Previous 0.2%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$10.24 - $14.96 $1.54 Million - $2.26 Million	-150,786 Reduced 55.37%	121,517 $1.82 Million
Q2 2025 Aug 14, 2025	SELL	$6.83 - $12.16 $496,370 - $883,728	-72,675 Reduced 21.07%	272,303 $3.17 Million
Q1 2025 May 15, 2025	BUY	$6.07 - $8.66 $174,190 - $248,516	28,697 Added 9.07%	344,978 $2.56 Million
Q4 2024 Feb 14, 2025	BUY	$4.37 - $6.78 $156,878 - $243,395	35,899 Added 12.8%	316,281 $1.9 Million
Q3 2024 Nov 14, 2024	BUY	$3.37 - $5.12 $220,323 - $334,735	65,378 Added 30.41%	280,382 $1.44 Million

Q1 2024 May 15, 2024	BUY	$2.88 - $4.8 $282,816 - $471,360	98,200 Added 84.07%	215,004 $690,000
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $348,923 - $537,503	100,845 Added 631.9%	116,804 $572,000
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $559,646 - $931,640	-110,384 Reduced 87.37%	15,959 $86,000
Q2 2023 Aug 14, 2023	BUY	$6.19 - $8.78 $115,653 - $164,045	18,684 Added 17.35%	126,343 $847,000
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $124 - $161	16 Added 0.01%	107,659 $950,000
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $340,030 - $507,330	54,318 Added 101.86%	107,643 $822,000
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $42,692 - $83,216	-6,568 Reduced 10.97%	53,325 $380,000
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $2,297 - $5,288	-359 Reduced 0.6%	59,893 $485,000
Q1 2022 May 16, 2022	SELL	$10.12 - $28.9 $243,365 - $694,987	-24,048 Reduced 28.53%	60,252 $836,000
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $341,607 - $500,128	-13,572 Reduced 13.87%	84,300 $2.37 Million
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $62,081 - $82,451	2,068 Added 2.16%	97,872 $3.33 Million
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $41,499 - $57,431	1,288 Added 1.36%	95,804 $3.92 Million
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $538,146 - $978,368	-14,443 Reduced 13.26%	94,516 $3.81 Million
Q4 2020 Feb 16, 2021	SELL	$45.01 - $65.47 $2.66 Million - $3.87 Million	-59,048 Reduced 35.15%	108,959 $6.44 Million
Q3 2020 Nov 16, 2020	BUY	$35.79 - $48.81 $5.64 Million - $7.69 Million	157,594 Added 1513.44%	168,007 $8.17 Million
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $259,804 - $503,780	10,413 New	10,413 $504,000

Others Institutions Holding ADPT

# of Institutions

290

Shares Held

147M

Call Options Held

23.5K

Put Options Held

33.3K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $2.01B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account